Cite
HARVARD Citation
Heck, M. et al. (2016). A 2‐Gene Panel Derived From Prostate Cancer‐Enhanced Transcripts in Whole Blood Is Prognostic for Survival and Predicts Treatment Benefit in Metastatic Castration‐Resistant Prostate Cancer. Prostate. 76 (13), pp. 1160-1168. [Online].